Phase 1b CMV-MVA Triplex Vaccine, MVA-based CMV immunotherapy

This trial by City of Hope evaluates the safety and potential efficacy of the vaccine alone or with antiviral agents in haploidentical stem cell transplant donors and recipients at risk for CMV viremia. Eligible patients include those with hematologic malignancies undergoing transplant at sites in Duarte, Atlanta, and Boston.